Papers
6
Total Citations
43
H-Index
4
About
Dr. Giulia Marvaso is a leading oncologic surgeon and researcher whose work centers on precision surgical oncology for prostate, oropharyngeal, and testicular cancers. Her major contributions lie at the intersection of advanced surgical techniques and real-world evidence. She has pioneered the use of ex vivo fluorescence confocal microscopy (FCM) for intraoperative margin assessment during robot-assisted radical prostatectomy (RARP), demonstrating in her most cited work (14 citations) that FCM can rival frozen section analysis in accuracy. Dr. Marvaso has also reshaped treatment paradigms for oligometastatic prostate cancer, showing that multimodality therapy—combining RARP with androgen deprivation and radiotherapy—improves outcomes over ADT alone (8 citations). In HPV-positive oropharyngeal cancer, her real-world data (9 citations) compare upfront transoral robotic surgery (TORS) against intensity-modulated radiation therapy, providing critical guidance for treatment selection. Notably, she is leading a phase 3 randomized trial (4 citations) evaluating augmented reality during RARP to reduce positive surgical margins. Her work on robot-assisted retroperitoneal lymph node dissection for testis cancer further underscores her commitment to minimally invasive innovation. With a portfolio spanning surgical outcomes, toxicity profiles, and cutting-edge technology, Dr. Marvaso is shaping the future of precision cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6